Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05477901 · ClinicalTrials.gov registry record · NA

Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)

A NA study of Inflammation and Family Relations, sponsored by New York State Psychiatric Institute.

Recruiting
Registry status
NA
Development phase
450
Enrollment target
2
Study locations

NCT05477901 is a NA study of Inflammation and Family Relations that is actively recruiting participants, run by New York State Psychiatric Institute. The registered enrollment target is 450 participants, above the 285-participant average among 132 other Inflammation trials with a reported enrollment target (58% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05477901, a NA study of Inflammation and Family Relations, is actively recruiting participants, sponsored by New York State Psychiatric Institute.

RECRUITING
Registry status
NA
Development phase
450 participants
Enrollment target
2
Study locations

Study Summary

This study examines the impact of Auxilio Brasil (AB), a cash transfer program to mothers of school-age children, on resource-deprived populations in Brazil and its protective effects on child neurodevelopment and mental health. The investigators will conduct a randomized clinical trial (RCT) among those already receiving AB in which 300 families will be randomized in a 1:1 ratio to receive either a high ($40/month) or low ($2/month) supplemental transfer for 2 years. Three hundred children (index child participants; 7-10 years old) will be enrolled across both study arms. Additionally, up to 150 siblings ("sibling participants;" 7-10 years old) will be enrolled. Eligible families who decide to participate will sign a study-specific informed consent (mother) and assent (child) form. The UNIFESP team will conduct the respective assessments at baseline, approximately 8- and 16- months, 24-months and approximately 6-months post-RCT. Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment. Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol. Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model; and (ii) whether cash transfer-related effects persist 6 months post-RCT.

Conditions Studied

Inflammation Family Relations HPA CBCL

Interventions

  • OTHER Supplemental cash transfer

Study Locations (2)

New York

  • New York State Psychiatric Institute - New York

São Paulo

  • UNIFESP - São Paulo

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2025-05-17
Est. Completion 2028-01-01
Phase NA

Sponsor

New York State Psychiatric Institute

364 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05477901

The ClinicalTrials.gov registry entry for NCT05477901 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 285-participant average among 132 other Inflammation trials with a reported enrollment target (58% higher). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Supplemental cash transfer is the first listed.

NCT05477901 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, São Paulo.

Frequently Asked Questions

What is clinical trial NCT05477901 about?

NCT05477901 is a clinical study titled "Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)". This study examines the impact of Auxilio Brasil (AB), a cash transfer program to mothers of school-age children, on resource-deprived populations in Brazil and its protective effects on child neurodevelopment and mental health. The investigators will conduct a randomized clinical trial (RCT) among ...

What is the current status of trial NCT05477901?

This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2025-05-17. Estimated completion is 2028-01-01.

What conditions does trial NCT05477901 study?

This clinical trial studies the following conditions: Inflammation, Family Relations, HPA, CBCL.

What interventions are being tested in trial NCT05477901?

The interventions under investigation include: Supplemental cash transfer (OTHER).

Who is sponsoring clinical trial NCT05477901?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05477901 being conducted?

This trial has 2 study locations across New York, São Paulo. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Inflammation

All registered trials for this condition

Family Relations

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.